Skip to main content

Year: 2024

Toll Brothers Announces New Luxury Home Community Coming Soon to Hurst, Texas in Dallas-Fort Worth Area

HURST, Texas, Dec. 17, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Toll Brothers at Adkins Park, is coming soon to Hurst, Texas. This new community will include a refined collection of single-family homes located at Precinct Line Road and Doppler Court in Hurst. Site work is underway, and the community is anticipated to open for sale in early 2025. Showcasing one- and two-story single-family homes on expansive 70-foot home sites, Toll Brothers at Adkins Park offers spacious, open-concept floor plans ranging from 3,089 to over 4,940+ square feet with 4 to 6 bedrooms, modern architecture, and outstanding options for personalization at the Toll Brothers Design Studio. Anticipated pricing starts in the $1,000,000s.“Our new Toll Brothers...

Continue reading

Applied Digital Announces Ellendale HPC Data Center Development Milestone

Ellendale HPC Data Center Is Now Energized ELLENDALE, N.D., Dec. 17, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) applications, today announced a major milestone in the development of its purpose-built HPC data center in Ellendale, N.D., with the successful energization of its on-site main substation transformer. This milestone signals the facility’s progression into the next stage of its build-out, setting the foundation for a data center capable of supporting cutting-edge AI and high-performance computing. The energization of the on-site main substation transformer marks a critical step toward bringing the Ellendale HPC campus fully online. This milestone...

Continue reading

Worthington Enterprises Reports Second Quarter Fiscal 2025 Results

COLUMBUS, Ohio, Dec. 17, 2024 (GLOBE NEWSWIRE) — Worthington Enterprises, Inc. (NYSE: WOR), a market-leading designer and manufacturer of innovative products and solutions that serve customers in the building products and consumer products end markets, today reported results for its fiscal 2025 second quarter ended November 30, 2024. Second Quarter Highlights (all comparisons to the second quarter of fiscal 2024):Net sales of $274.0 million, decreased 8% driven by the deconsolidation of the former Sustainable Energy Solutions segment (“SES”)Adjusted EPS of $0.60 from continuing operations (diluted), up 5% and adjusted EBITDA of $56.2 million, up 2%, despite lower net salesRepurchased 200,000 shares of common stock for $8.1 million leaving 5,715,000 shares remaining on the Company’s share repurchase authorizationDeclared...

Continue reading

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at 4:30 p.m. EST ROCKAWAY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today it has entered into a definitive agreement to acquire NeuroMetrix, Inc. (“NeuroMetrix” or “NURO”) (Nasdaq: NURO), including its Quell platform, positioning itself as a diversified, commercial-scale player in non-invasive health and wellness treatments. NURO is a commercial stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets....

Continue reading

NeuroMetrix to be Acquired by electroCore

NeuroMetrix shareholders to receive cash and Contingent Value Rights WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (“NeuroMetrix” or the “Company”) (Nasdaq: NURO) today announced it has entered into a definitive merger agreement whereby electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial stage bioelectronic medicine and wellness company, will acquire NeuroMetrix. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close late in the first quarter of 2025. Under the terms of the merger agreement, a subsidiary of electroCore will merge with NeuroMetrix and NeuroMetrix will become a wholly owned subsidiary of electroCore. The shareholders of NeuroMetrix will be entitled to receive the equivalent of the balance of NeuroMetrix’s net cash at the closing...

Continue reading

Willis Lease Finance Corporation Welcomes Stephen Jones to its Board of Directors

Jones brings extensive airline, senior management, and governance experience COCONUT CREEK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, is pleased to announce the appointment of Stephen Jones to its Board of Directors (the “Board”) effective January 1, 2025. Mr. Jones has a 40-year career in the airline and energy industries. An engineer by training, he began in international oil and gas development, focusing on gas turbine cogeneration projects in North America and Australia. Joining Air New Zealand in 2001 as VP of Investor Relations, he played a key role in its post September 11th transformation. He managed Freedom Air, the Tasman and Pacific Islands airline, and the...

Continue reading

Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025

BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that its two wholly-owned subsidiaries, Orocidin A/S (“Orocidin”) and Bio-Convert ApS (“Bio-Convert”), expect to begin pilot efficacy studies in patients with periodontitis and oral leukoplakia in 2025. As of today both Orocidin and Bio-Convert are preclinical phase biopharmaceutical companies, which was incorrectly stated in previous press releases. About Nordicus Partners Corporation Nordicus Partners Corporation specializes in providing Nordic and U.S. life sciences companies with the best possible conditions to establish...

Continue reading

Nokia Corporation: Repurchase of own shares on 17.12.2024

Nokia CorporationStock Exchange Release17 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 17.12.2024 Espoo, Finland – On 17 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 884,897 4.23CEUX – –BATE – –AQEU – –TQEX – –Total 884,897 4.23* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Notice of extraordinary general meeting 2025 in Fingerprint Cards AB (publ)

The shareholders of Fingerprint Cards AB (publ), reg. no. 556154-2381 (the “Company” or “Fingerprints”), are hereby invited to attend an Extraordinary General Meeting (the “EGM” or “Meeting”) to be held at 10:00 a.m. (CET) on 17 January 2025, at Gernandt & Danielsson Advokatbyrå, Hamngatan 2, 111 47, Stockholm, Sweden. The entrance to, and registration for, the Meeting will open at 9:30 a.m (CET). The Board of Directors has decided, pursuant to the Company’s articles of association, that shareholders shall have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the Meeting by attending in person, through a proxy or by postal voting. A. Right to participate at the Meeting In order to participate in the EGM, shareholders shall:be registered in the register...

Continue reading

AMAYA BIG SKY CAPITAL ANNOUNCES SIGNING OF BUSINESS COMBINATION AGREEMENT WITH FLIGHT FOOD & BEVERAGE PARTNERS FOR PROPOSED QUALIFYING TRANSACTION

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC, Dec. 17, 2024 (GLOBE NEWSWIRE) — Amaya Big Sky Capital Corp. (“Amaya” or the “Company”) (TSX-V: AMYA.P), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSX-V”), is pleased to announce today, further to its press release dated September 19, 2024, that it has executed a definitive business combination agreement (the “Definitive Agreement”) with Flight Food & Beverage Partners Inc. (“Flight”), an arm’s length party, and 1515959 B.C. Ltd. (“Subco”), a wholly-owned subsidiary of the Company, in respect of a proposed reverse takeover transaction (the “Transaction”) intended to constitute Amaya’s “qualifying transaction”, as defined under Policy 2.4 of the TSX-V. Upon completion of the Transaction,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.